INVIVO THERAPEUTICS CORP has a total of 31 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2009. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Republic of Korea. Its main competitors in its focus markets pharmaceuticals, medical technology and macromolecular chemistry and polymers are FARCO GMBH, KNEZEVICH CHARLES and INTERSTITIAL THERAPEUTICS.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 11 | |
#2 | WIPO (World Intellectual Property Organization) | 9 | |
#3 | Republic of Korea | 3 | |
#4 | EPO (European Patent Office) | 2 | |
#5 | Australia | 1 | |
#6 | Brazil | 1 | |
#7 | Canada | 1 | |
#8 | China | 1 | |
#9 | Japan | 1 | |
#10 | Taiwan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Medical technology | |
#3 | Macromolecular chemistry and polymers | |
#4 | Packaging and shipping | |
#5 | Civil engineering | |
#6 | Agriculture |
# | Name | Total Patents |
---|---|---|
#1 | Reynolds Francis M | 20 |
#2 | Langer Robert S | 19 |
#3 | Pritchard Christopher D | 13 |
#4 | Woodard Eric J | 13 |
#5 | Hess Brian | 10 |
#6 | Aimetti Alex | 7 |
#7 | Aimetti Alex A | 5 |
#8 | O'Shea Timothy | 5 |
#9 | Slotkin Jonathan R | 4 |
#10 | Prifti Fioleda | 4 |
Publication | Filing date | Title |
---|---|---|
US2017151416A1 | Methods and Systems for Delivery of a Trail of a Therapeutic Substance into an Anatomical Space | |
US2017151286A1 | Compositions and methods for preparing an injectable medium for administration into the central nervous system | |
WO2014160377A1 | Crosslinkable trehalose for the covalent incorporation in hydrogels and methods of use | |
US2014012314A1 | Cupped forceps | |
WO2013134760A2 | Protective packaging with product preparation features incorporated | |
WO2013082590A1 | Peg based hydrogel for peripheral nerve injury applications and compositions and method of use of synthetic hydrogel sealants | |
TW201313263A | Poly((lactic-co-glycolic acid)-B-lysine) and process for synthesizing a block copolymer of PLGA {poly(lactic-co-glycolic acid)} and PLL (poly-E-CBZ-L-lysine) | |
BRPI0913697A2 | spinal cord injury, inflammation and autoimmune disease: controlled local release therapeutic agents. |